rxstat › Prices in New Brunswick › Anifrolumab
Anifrolumab (Saphnelo) price and coverage in New Brunswick
Anifrolumab 150 mg/ml solution lists at $1722.64 per vial in New Brunswick on the New Brunswick Drug Plans' price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Anifrolumab is covered by the New Brunswick Drug Plans only under Special Authorization: your prescriber has to request coverage, and it applies to patients who meet set criteria.
Price by strength in New Brunswick
| Strength and form | Lowest price | Brand |
|---|---|---|
| 150 mg/ml Solution1 product · special approval | $1722.64/vial | – |
All 1 products listed in New Brunswick
| Product | Price | Coverage |
|---|---|---|
| 150 mg/ml Solution | ||
| SaphneloAZE · DIN 02522845 | $1722.64/vial | Special approval |
What you'll pay at the pharmacy
These are the prices the New Brunswick Drug Plans lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
No active shortage is reported for Anifrolumab in Canada. Full drug page.
Anifrolumab price in other provinces
Common questions
How much does Anifrolumab cost in New Brunswick?
Anifrolumab 150 mg/ml solution lists at $1722.64 per vial in New Brunswick on the New Brunswick Drug Plans' price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Is Anifrolumab covered in New Brunswick?
Anifrolumab is covered by the New Brunswick Drug Plans only under Special Authorization: your prescriber has to request coverage, and it applies to patients who meet set criteria.
Source: New Brunswick Drug Plans Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.